is editor-in-chief of The Verge, host of the Decoder podcast, and co-host of The Vergecast. Today, I’m talking with Prashanth Chandrasekar, who is the CEO of Stack Overflow. I last had Prashanth on ...

Developers are navigating confusing gaps between expectation and reality. So are the rest of us. Depending who you ask, AI-powered coding is either giving software developers an unprecedented ...

Shia LaBeouf has been quite the busy star, having just wrapped his third film of the year, so it was a rare sight indeed to see the actor on a coffee run in Los Angeles. LaBeouf was also sporting a ...

GameSpot may get a commission from retail offers. Microsoft has announced that the next Xbox Developer Direct broadcast is coming up in January 2026, but it won't have everything Microsoft plans to ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Vivek Yadav, an engineering manager from ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...

For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including already-approved CAR T products. The FDA is eyeing regulatory changes that ...

Imugene (ASX:IMU) is planning a phase III blood cancer trial, after the US Food and Drug Administration (FDA) delivered positive feedback on the company’s lead asset, Azer-cel. In effect, the agency ...